Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 37 publications
Comparing immune-checkpoint inhibitor-mediated inflammatory arthritis to polymyalgia rheumatica: a prospective cohort study.
Journal: Journal for immunotherapy of cancer
Published: May 11, 2026
Pre-treatment naïve T cells are associated with severe irAE following PD-1/CTLA4 checkpoint blockade for melanoma.
Journal: bioRxiv : the preprint server for biology
Published: November 24, 2025
Arthroplasty Joint Histology and Surgical Outcomes in Patients on Immune Checkpoint Inhibitors: A Single-Center Case Series.
Journal: The Journal of rheumatology
Published: November 15, 2025
Oral glucocorticoid treatment for checkpoint inhibitor-associated inflammatory arthritis does not affect cancer progression-free survival: a RADIOS Registry study.
Journal: Annals of the rheumatic diseases
Published: November 11, 2025
Necrotizing and Nonnecrotizing Granulomatous Reactions in Patients With Cancer Treated With Immune Checkpoint Inhibitors: A Systematic Literature Review.
Journal: The Journal of rheumatology
Published: June 27, 2025
Use of Apremilast for the Treatment of Immune Checkpoint Inhibitor Psoriasis and Psoriatic Arthritis.
Journal: Arthritis care & research
Published: April 01, 2025
Prioritising domains of glucocorticoid therapy to measure in trials: Results from a modified delphi exercise from the OMERACT glucocorticoid impact working group.
Journal: Seminars in arthritis and rheumatism
Published: August 05, 2024
The Need for Classification Criteria of Immune Checkpoint Inhibitor-induced inflammatory Arthritis: A Scoping Review.
Journal: Rheumatic diseases clinics of North America
Published: April 26, 2024
Incidence of checkpoint inhibitor-associated inflammatory arthritis, immunomodulation and mortality in cancer patients on immunotherapy: a retrospective cohort study.
Journal: Rheumatology (Oxford, England)
Published: March 07, 2024
Erratum to "2023 American College of Rheumatology and American Association of Hip and Knee Surgeons Clinical Practice Guideline for the Optimal Timing of Elective Hip or Knee Arthroplasty for Patients With Symptomatic Moderate-to-Severe Osteoarthritis or Advanced Symptomatic Osteonecrosis With Secondary Arthritis for Whom Nonoperative Therapy Is Ineffective" [The Journal of Arthroplasty 38 (2023) 2193-2201].
Journal: The Journal of arthroplasty
Published: December 04, 2023
Evolving and evaluating the OMERACT fellows program: insights and implications from OMERACT 2023 fellows.
Journal: Seminars in arthritis and rheumatism
Published: November 10, 2023
Last Updated: 09/26/2026